Clinical Trial Update: Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of everolimus for Birt-Hogg-Dube syndrome-associated kidney cancer or sporadic chromophobe renal cancer was terminated with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Birt-hogg-dube Syndrome
• Renal Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Renal Cancer, Birt-Hogg-Dube Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2019-03-07